Seelos Therapeutics, Inc. Selling, General and Administrative Expense
Seelos Therapeutics, Inc. reported Selling, General and Administrative Expense of $4.44 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-11-08
- Seelos Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-09-30 was $4.44M, a 95.39% increase year-over-year.
- Seelos Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-06-30 was $3.74M, a 1.41% increase year-over-year.
- Seelos Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-03-31 was $3.99M, a 37.39% increase year-over-year.
- Seelos Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2011-09-30 was $2.27M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month |
|---|---|---|---|
| 2012-09-30 | $4.44M 10-Q · filed 2012-11-08 | $8.18M derived: sum of 2 quarters · filed 2012-11-08 | $12.19M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $3.74M 10-Q · filed 2012-08-09 | $7.73M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $3.99M 10-Q · filed 2012-05-10 | ||
| 2011-09-30 | $2.27M 10-Q · filed 2012-11-08 | $5.96M derived: sum of 2 quarters · filed 2012-11-08 | $8.86M 10-Q · filed 2012-11-08 |
| 2011-06-30 | $3.69M 10-Q · filed 2012-08-09 | $6.59M 10-Q · filed 2012-08-09 | |
| 2011-03-31 | $2.91M 10-Q · filed 2012-05-10 |